Name: Humana Inc. (NYSE:HUM) | Income Statement (Quarterly)
Creator: Stock Analysis on Net

Income Statement
Quarterly Data

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Download chart

Humana Inc., consolidated income statement (quarterly data)

US$ in millions

3 months ended:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Premiums	27,951)	28,142)	28,261)	25,128)	25,099)	25,495)	25,550)	21,275)	21,468)	22,266)	22,703)	19,835)	19,885)	19,978)	20,124)	18,364)	18,904)	18,556)	18,362)	15,809)	15,712)	15,776)	15,651)
Services	1,103)	1,100)	1,062)	1,040)	1,016)	978)	999)	1,004)	1,159)	1,349)	1,264)	1,253)	845)	491)	466)	484)	457)	450)	424)	336)	393)	355)	355)
External revenues	29,054)	29,242)	29,323)	26,168)	26,115)	26,473)	26,549)	22,279)	22,627)	23,615)	23,967)	21,088)	20,730)	20,469)	20,590)	18,848)	19,361)	19,006)	18,786)	16,145)	16,105)	16,131)	16,006)
Investment income (loss)	343)	298)	288)	294)	308)	274)	193)	160)	172)	47)	3)	(34)	(33)	176)	78)	214)	714)	77)	149)	150)	136)	114)	101)
Benefits	(25,120)	(25,039)	(25,124)	(22,782)	(21,745)	(22,009)	(21,858)	(18,582)	(18,384)	(19,099)	(19,625)	(17,438)	(17,316)	(17,149)	(17,296)	(16,213)	(15,611)	(14,175)	(15,629)	(13,689)	(13,357)	(13,318)	(13,493)
Operating costs	(3,339)	(3,148)	(3,042)	(3,827)	(3,271)	(3,111)	(2,979)	(3,551)	(3,061)	(3,173)	(2,886)	(3,395)	(2,603)	(2,116)	(2,007)	(3,068)	(2,513)	(2,354)	(2,117)	(2,129)	(1,889)	(1,703)	(1,660)
Depreciation and amortization	(210)	(212)	(209)	(201)	(201)	(191)	(186)	(182)	(182)	(175)	(170)	(160)	(150)	(144)	(142)	(127)	(128)	(119)	(115)	(115)	(127)	(109)	(107)
Operating expenses	(28,669)	(28,399)	(28,375)	(26,810)	(25,217)	(25,311)	(25,023)	(22,315)	(21,627)	(22,447)	(22,681)	(20,993)	(20,069)	(19,409)	(19,445)	(19,408)	(18,252)	(16,648)	(17,861)	(15,933)	(15,373)	(15,130)	(15,260)
Income from operations	728)	1,141)	1,236)	(348)	1,206)	1,436)	1,719)	124)	1,172)	1,215)	1,289)	61)	628)	1,236)	1,223)	(346)	1,823)	2,435)	1,074)	362)	868)	1,115)	847)
Gain on sale of Gentiva Hospice	—)	—)	—)	—)	—)	—)	—)	(3)	240)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Interest expense	(169)	(168)	(159)	(146)	(114)	(120)	(113)	(108)	(102)	(101)	(90)	(91)	(88)	(79)	(68)	(72)	(75)	(76)	(60)	(58)	(62)	(60)	(62)
Other income (expense), net	92)	(55)	(63)	(97)	6)	(54)	8)	(84)	(13)	8)	21)	(30)	1,096)	(419)	(115)	(40)	7)	227)	(297)	289)	82)	174)	(39)
Income before income taxes and equity in net earnings (losses)	651)	918)	1,014)	(591)	1,098)	1,262)	1,614)	(71)	1,297)	1,122)	1,220)	(60)	1,636)	738)	1,040)	(458)	1,755)	2,586)	717)	593)	888)	1,229)	746)
Provision for income taxes	(155)	(223)	(251)	75)	(256)	(296)	(359)	58)	(107)	(427)	(286)	51)	(120)	(183)	(233)	178)	(450)	(783)	(252)	(79)	(200)	(301)	(183)
Equity in net earnings (losses)	(16)	(17)	(24)	(24)	(12)	(10)	(17)	(5)	3)	2)	(4)	(4)	15)	33)	21)	6)	35)	25)	8)	(2)	1)	12)	3)
Net income	480)	678)	739)	(540)	830)	956)	1,238)	(18)	1,193)	697)	930)	(13)	1,531)	588)	828)	(274)	1,340)	1,828)	473)	512)	689)	940)	566)
Net (income) loss attributable to noncontrolling interests	—)	1)	2)	(1)	2)	3)	1)	3)	2)	(1)	—)	(1)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Net income attributable to Humana	480)	679)	741)	(541)	832)	959)	1,239)	(15)	1,195)	696)	930)	(14)	1,531)	588)	828)	(274)	1,340)	1,828)	473)	512)	689)	940)	566)

External revenues have demonstrated a consistent upward trajectory over the observed period, expanding from approximately 16 billion USD in early 2019 to over 29 billion USD by late 2024. This growth is primarily driven by a steady increase in premiums, which rose from 15.6 billion USD in the first quarter of 2019 to nearly 28 billion USD by the third quarter of 2024. Additionally, service-based revenues experienced a significant structural shift starting in late 2021, transitioning from quarterly averages below 500 million USD to levels consistently exceeding 1 billion USD.

Expense and Cost Structure: Operating expenses have scaled in tandem with revenue growth, though the increase has been non-linear. Benefit payments, the largest cost component, grew from 13.5 billion USD in early 2019 to 25.1 billion USD by late 2024. Operating costs, excluding depreciation, have also trended upward, with a notable increase in volatility beginning in 2020. Depreciation and amortization expenses have shown a slow but steady increase, rising from 107 million USD to 210 million USD over the analyzed timeframe.
Operational Profitability and Seasonality: Income from operations exhibits significant volatility and a recurring seasonal pattern. A consistent trend of diminished performance or operational losses is observed during the fourth quarter of each year, specifically in December 2020, December 2021, December 2022, and December 2023. Conversely, the first and second quarters typically yield the strongest operational results. This cyclicality suggests a recurring year-end pressure on margins or a periodic alignment of benefit payouts and operating costs.
Investment Income and Non-Operating Items: Investment income has been highly inconsistent, characterized by sharp fluctuations. While it remained relatively low or negative in some periods (such as the second half of 2021), it saw a marked recovery and growth through 2023 and 2024, reaching 343 million USD in the most recent quarter. Interest expenses have trended upward, nearly tripling from approximately 60 million USD in 2019 to 169 million USD by late 2024, indicating an increase in the cost of debt or higher leverage.
Net Income Trends: Net income mirrors the volatility seen in operational results. The period is marked by alternating phases of strong profitability and sharp declines. Notable net losses were recorded in December 2020, December 2021, December 2022, and December 2023. Despite these periodic losses, the company maintained a general ability to generate positive net income in the intervening quarters, although the margin between external revenues and total operating expenses has remained narrow relative to the scale of the business.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?

Humana Inc. (NYSE:HUM)

Income StatementQuarterly Data

Income Statement
Quarterly Data